Please enable JavaScript to continue using this application.

Compare $CLDX vs $IRON | Chartloom

Compare

$CLDX vs $IRON

Celldex Therapeutics Inc · Disc Medicine Inc

CLDX

Celldex Therapeutics Inc

IRON

Disc Medicine Inc

Compare $CLDX vs $IRON

Comparing Celldex Therapeutics Inc and Disc Medicine Inc

CLDXCelldex Therapeutics Inc

IRONDisc Medicine Inc

CLDXCelldex Therapeutics Inc

Market cap

$2.35B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,016.81x

Rev growth (TTM)

-97.3%

YTD performance

10.7%

52W performance

9.7%

FCF yield

-10.3%

IRONDisc Medicine Inc

Market cap

$2.37B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-21.5%

52W performance

-11.7%

FCF yield

-8.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLDX

IRON

Detailed metrics comparison

CLDX

Celldex Therapeutics Inc

IRON

Disc Medicine Inc

Market Cap

CLDX$2.35B

IRON$2.37B

Enterprise Value

CLDX$2.30B

IRON$2.33B

Price

CLDX$29.89

IRON$62.06

P/E Ratio

CLDXN/A

IRONN/A

P/S Ratio

CLDX14,848.52x

IRON0.00x

EV/Sales

CLDX14,548.18x

IRON0.00x

EV/EBITDA

CLDX0.00x

IRON0.00x

P/B Ratio

CLDX3.48x

IRON3.84x

P/FCF Ratio

CLDXN/A

IRONN/A

EV/FCF

CLDX-9.49x

IRON-11.80x

PEG Ratio

CLDXN/A

IRONN/A

Forward P/E (NTM)

CLDXN/A

IRONN/A

Forward P/S (NTM)

CLDX1,016.81x

IRONN/A

Revenue (TTM)

CLDX$158K

IRON$0

Revenue Growth (YoY)

CLDX-97.3%

IRONN/A

Forward Rev Growth

CLDX637.2%

IRON300.5%

Gross Margin (TTM)

CLDX17.6%

IRON0.0%

Operating Margin (TTM)

CLDX0.0%

IRON0.0%

EBITDA Margin (TTM)

CLDX-204070.9%

IRON0.0%

Net Margin (TTM)

CLDX-190220.9%

IRON0.0%

FCF Margin (TTM)

CLDX-153231.0%

IRONN/A

Net Income (TTM)

CLDX$-301M

IRON$-246M

FCF (TTM)

CLDX$-242M

IRON$-198M

EPS (TTM)

CLDX-$3.86

IRON-$6.36

ROE (TTM)

CLDX-5235.0%

IRON-3717.0%

ROA (TTM)

CLDX-4761.0%

IRON-3365.0%

ROIC (TTM)

CLDX-5235.0%

IRON-3522.0%

Cash

CLDX$47M

IRON$99M

Debt

CLDX$0

IRON$59M

Net Cash/Debt

CLDX$47M

IRON$39M

Current Ratio (TTM)

CLDX11.82x

IRON24.14x

Quick Ratio (TTM)

CLDX11.71x

IRON23.64x

Debt/Equity (TTM)

CLDX0.00x

IRON0.09x

Debt/Assets (TTM)

CLDX0.0%

IRON0.0%

Interest Coverage (TTM)

CLDXN/A

IRONN/A

Net Debt/EBITDA (TTM)

CLDX0.00x

IRON0.00x

Beta

CLDX0.99

IRON0.95

52W Performance

CLDX9.7%

IRON-11.7%

YTD Performance

CLDX10.7%

IRON-21.5%

% from 52W High

CLDX-33.8%

IRON-37.6%

% from 52W Low

CLDX35.2%

IRON55.2%

Asset Turnover (TTM)

CLDX0.00x

IRON0.00x

FCF Yield (TTM)

CLDX-10.3%

IRON-8.3%

Earnings Yield (TTM)

CLDX-12.8%

IRON-10.4%

Dividend Yield (TTM)

CLDXN/A

IRONN/A

Rule of 40

CLDX-153,328.3

IRON0.0

EV/GP/RG

CLDX42.93

IRONN/A

Ticker research

View CLDX research View IRON research

Metric	CLDX Celldex Therapeutics Inc	IRON Disc Medicine Inc
Market & Valuation
Market Cap	$2.35B	$2.37B
Enterprise Value	$2.30B	$2.33B
Price	$29.89	$62.06
P/E Ratio	N/A	N/A
P/S Ratio	14,848.52x	0.00x
EV/Sales	14,548.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.48x	3.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.49x	-11.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,016.81x	N/A
Revenue & Growth
Revenue (TTM)	$158K	$0
Revenue Growth (YoY)	-97.3%	N/A
Forward Rev Growth	637.2%	300.5%
Profitability
Gross Margin (TTM)	17.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204070.9%	0.0%
Net Margin (TTM)	-190220.9%	0.0%
FCF Margin (TTM)	-153231.0%	N/A
Net Income (TTM)	$-301M	$-246M
FCF (TTM)	$-242M	$-198M
EPS (TTM)	-$3.86	-$6.36
ROE (TTM)	-5235.0%	-3717.0%
ROA (TTM)	-4761.0%	-3365.0%
ROIC (TTM)	-5235.0%	-3522.0%
Financial Health
Cash	$47M	$99M
Debt	$0	$59M
Net Cash/Debt	$47M	$39M
Current Ratio (TTM)	11.82x	24.14x
Quick Ratio (TTM)	11.71x	23.64x
Debt/Equity (TTM)	0.00x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	0.95
52W Performance	9.7%	-11.7%
YTD Performance	10.7%	-21.5%
% from 52W High	-33.8%	-37.6%
% from 52W Low	35.2%	55.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-10.3%	-8.3%
Earnings Yield (TTM)	-12.8%	-10.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-153,328.3	0.0
EV/GP/RG	42.93	N/A
Ticker research	View CLDX research	View IRON research

Valuation

P/S Ratio

IRON

0.00x

CLDX

14,848.52x

EV/FCF

IRON

-11.80x

CLDX

-9.49x

Growth & revenue

Revenue Growth TTM

CLDX

-97.3%

Forward Revenue Growth

CLDX

637.2%

IRON

300.5%

Profitability & performance

Gross Margin

CLDX

17.6%

IRON

0.0%

ROE

IRON

-3717.0%

CLDX

-5235.0%

FCF Yield %

IRON

-8.3%

CLDX

-10.3%

52-Week Performance

CLDX

9.7%

IRON

-11.7%

Detailed metrics comparison

CLDX

Celldex Therapeutics Inc

IRON

Disc Medicine Inc

Market Cap

CLDX$2.35B

IRON$2.37B

Enterprise Value

CLDX$2.30B

IRON$2.33B

Price

CLDX$29.89

IRON$62.06

P/E Ratio

CLDXN/A

IRONN/A

P/S Ratio

CLDX14,848.52x

IRON0.00x

EV/Sales

CLDX14,548.18x

IRON0.00x

EV/EBITDA

CLDX0.00x

IRON0.00x

P/B Ratio

CLDX3.48x

IRON3.84x

P/FCF Ratio

CLDXN/A

IRONN/A

EV/FCF

CLDX-9.49x

IRON-11.80x

PEG Ratio

CLDXN/A

IRONN/A

Forward P/E (NTM)

CLDXN/A

IRONN/A

Forward P/S (NTM)

CLDX1,016.81x

IRONN/A

Revenue (TTM)

CLDX$158K

IRON$0

Revenue Growth (YoY)

CLDX-97.3%

IRONN/A

Forward Rev Growth

CLDX637.2%

IRON300.5%

Gross Margin (TTM)

CLDX17.6%

IRON0.0%

Operating Margin (TTM)

CLDX0.0%

IRON0.0%

EBITDA Margin (TTM)

CLDX-204070.9%

IRON0.0%

Net Margin (TTM)

CLDX-190220.9%

IRON0.0%

FCF Margin (TTM)

CLDX-153231.0%

IRONN/A

Net Income (TTM)

CLDX$-301M

IRON$-246M

FCF (TTM)

CLDX$-242M

IRON$-198M

EPS (TTM)

CLDX-$3.86

IRON-$6.36

ROE (TTM)

CLDX-5235.0%

IRON-3717.0%

ROA (TTM)

CLDX-4761.0%

IRON-3365.0%

ROIC (TTM)

CLDX-5235.0%

IRON-3522.0%

Cash

CLDX$47M

IRON$99M

Debt

CLDX$0

IRON$59M

Net Cash/Debt

CLDX$47M

IRON$39M

Current Ratio (TTM)

CLDX11.82x

IRON24.14x

Quick Ratio (TTM)

CLDX11.71x

IRON23.64x

Debt/Equity (TTM)

CLDX0.00x

IRON0.09x

Debt/Assets (TTM)

CLDX0.0%

IRON0.0%

Interest Coverage (TTM)

CLDXN/A

IRONN/A

Net Debt/EBITDA (TTM)

CLDX0.00x

IRON0.00x

Beta

CLDX0.99

IRON0.95

52W Performance

CLDX9.7%

IRON-11.7%

YTD Performance

CLDX10.7%

IRON-21.5%

% from 52W High

CLDX-33.8%

IRON-37.6%

% from 52W Low

CLDX35.2%

IRON55.2%

Asset Turnover (TTM)

CLDX0.00x

IRON0.00x

FCF Yield (TTM)

CLDX-10.3%

IRON-8.3%

Earnings Yield (TTM)

CLDX-12.8%

IRON-10.4%

Dividend Yield (TTM)

CLDXN/A

IRONN/A

Rule of 40

CLDX-153,328.3

IRON0.0

EV/GP/RG

CLDX42.93

IRONN/A

Ticker research

View CLDX research View IRON research

Metric	CLDX Celldex Therapeutics Inc	IRON Disc Medicine Inc
Market & Valuation
Market Cap	$2.35B	$2.37B
Enterprise Value	$2.30B	$2.33B
Price	$29.89	$62.06
P/E Ratio	N/A	N/A
P/S Ratio	14,848.52x	0.00x
EV/Sales	14,548.18x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.48x	3.84x
P/FCF Ratio	N/A	N/A
EV/FCF	-9.49x	-11.80x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1,016.81x	N/A
Revenue & Growth
Revenue (TTM)	$158K	$0
Revenue Growth (YoY)	-97.3%	N/A
Forward Rev Growth	637.2%	300.5%
Profitability
Gross Margin (TTM)	17.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-204070.9%	0.0%
Net Margin (TTM)	-190220.9%	0.0%
FCF Margin (TTM)	-153231.0%	N/A
Net Income (TTM)	$-301M	$-246M
FCF (TTM)	$-242M	$-198M
EPS (TTM)	-$3.86	-$6.36
ROE (TTM)	-5235.0%	-3717.0%
ROA (TTM)	-4761.0%	-3365.0%
ROIC (TTM)	-5235.0%	-3522.0%
Financial Health
Cash	$47M	$99M
Debt	$0	$59M
Net Cash/Debt	$47M	$39M
Current Ratio (TTM)	11.82x	24.14x
Quick Ratio (TTM)	11.71x	23.64x
Debt/Equity (TTM)	0.00x	0.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.99	0.95
52W Performance	9.7%	-11.7%
YTD Performance	10.7%	-21.5%
% from 52W High	-33.8%	-37.6%
% from 52W Low	35.2%	55.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-10.3%	-8.3%
Earnings Yield (TTM)	-12.8%	-10.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-153,328.3	0.0
EV/GP/RG	42.93	N/A
Ticker research	View CLDX research	View IRON research